94 related articles for article (PubMed ID: 12968974)
1. Correlation with bone metastasis and high expression of CK 19 mRNA measured by quantitative RT-PCR in the bone marrow of breast cancer patients.
Tokunaga E; Ishida M; Kimura Y; Maehara Y
Breast J; 2003; 9(5):440-2. PubMed ID: 12968974
[No Abstract] [Full Text] [Related]
2. Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.
Slade MJ; Smith BM; Sinnett HD; Cross NC; Coombes RC
J Clin Oncol; 1999 Mar; 17(3):870-9. PubMed ID: 10071278
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
[TBL] [Abstract][Full Text] [Related]
4. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance.
Wu CH; Lin SR; Hsieh JS; Chen FM; Lu CY; Yu FJ; Cheng TL; Huang TJ; Huang SY; Wang JY
Dis Markers; 2006; 22(3):103-9. PubMed ID: 16788243
[TBL] [Abstract][Full Text] [Related]
5. Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer.
Benoy IH; Salgado R; Elst H; Van Dam P; Weyler J; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
Breast Cancer Res; 2005; 7(2):R210-9. PubMed ID: 15743502
[TBL] [Abstract][Full Text] [Related]
6. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.
Datta YH; Adams PT; Drobyski WR; Ethier SP; Terry VH; Roth MS
J Clin Oncol; 1994 Mar; 12(3):475-82. PubMed ID: 7509852
[TBL] [Abstract][Full Text] [Related]
7. Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
Slade MJ; Singh A; Smith BM; Tripuraneni G; Hall E; Peckitt C; Fox S; Graham H; Lüchtenborg M; Sinnett HD; Cross NC; Coombes RC
Int J Cancer; 2005 Mar; 114(1):94-100. PubMed ID: 15523696
[TBL] [Abstract][Full Text] [Related]
8. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of bone marrow micrometastasis detected by nested rt-PCR for keratin-19 in breast cancer patients.
Jung YS; Lee KJ; Kim HJ; Yim HE; Park JS; Soh EY; Kim MW; Park HB
Jpn J Clin Oncol; 2003 Apr; 33(4):167-72. PubMed ID: 12810830
[TBL] [Abstract][Full Text] [Related]
10. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
11. A new comprehensive gene expression panel to study tumor micrometastasis in patients with high-risk breast cancer.
Ferrucci PF; Rabascio C; Gigli F; Corsini C; Giordano G; Bertolini F; Martinelli G
Int J Oncol; 2007 Apr; 30(4):955-62. PubMed ID: 17332935
[TBL] [Abstract][Full Text] [Related]
12. The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19.
Schoenfeld A; Kruger KH; Gomm J; Sinnett HD; Gazet JC; Sacks N; Bender HG; Luqmani Y; Coombes RC
Eur J Cancer; 1997 May; 33(6):854-61. PubMed ID: 9291805
[TBL] [Abstract][Full Text] [Related]
13. Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.
Masuda TA; Kataoka A; Ohno S; Murakami S; Mimori K; Utsunomiya T; Inoue H; Tsutsui S; Kinoshita J; Masuda N; Moriyama N; Mori M
Int J Oncol; 2005 Mar; 26(3):721-30. PubMed ID: 15703829
[TBL] [Abstract][Full Text] [Related]
14. Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients.
Krüger W; Krzizanowski C; Holweg M; Stockschläder M; Kröger N; Jung R; Mross K; Jonat W; Zander AR
J Cancer Res Clin Oncol; 1996; 122(11):679-86. PubMed ID: 8898979
[TBL] [Abstract][Full Text] [Related]
15. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
Bozionellou V; Mavroudis D; Perraki M; Papadopoulos S; Apostolaki S; Stathopoulos E; Stathopoulou A; Lianidou E; Georgoulias V
Clin Cancer Res; 2004 Dec; 10(24):8185-94. PubMed ID: 15623593
[TBL] [Abstract][Full Text] [Related]
16. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R
Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA.
Ikeda N; Miyoshi Y; Motomura K; Inaji H; Koyama H; Noguchi S
Jpn J Cancer Res; 2000 Sep; 91(9):918-24. PubMed ID: 11011120
[TBL] [Abstract][Full Text] [Related]
18. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
[TBL] [Abstract][Full Text] [Related]
19. Limitations of molecular detection of CK19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically negative axillary lymph nodes.
Pitini V; Arrigo C; Amata C; La Torre I
Ann Oncol; 2005 Nov; 16(11):1845; author reply 1845-6. PubMed ID: 15972276
[No Abstract] [Full Text] [Related]
20. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.
Burchill SA; Bradbury MF; Pittman K; Southgate J; Smith B; Selby P
Br J Cancer; 1995 Feb; 71(2):278-81. PubMed ID: 7530983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
